Mining potential functionally significant polymorphisms at the ATP Binding-Cassette transporter genes

Current Pharmacogenomics and Personalized Medicine

Volumn 7 1, Issue , 2009, Pages 40-58

  Wang, Z ^a   Wang, J ^a   Chong, S S ^a   Lee, C G L ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b National Cancer Center   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

ABC transporter family; Association study; Drug response; Functional polymorphism; SNP

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ABC TRANSPORTER; ABC TRANSPORTER A2; ABC TRANSPORTER B11; ABC TRANSPORTER C1; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; ESTRAMUSTINE; ETOPOSIDE; FLUOROURACIL; IMATINIB; IRINOTECAN; MERCAPTOPURINE; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; MULTIDRUG RESISTANCE PROTEIN 6; MULTIDRUG RESISTANCE PROTEIN 7; MULTIDRUG RESISTANCE PROTEIN 8; PACLITAXEL; TENIPOSIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; ABC TRANSPORTER 2; ABC TRANSPORTER 3; ABC TRANSPORTER 4; ABC TRANSPORTER 5; ABC TRANSPORTER 6; ABC TRANSPORTER A1; ABC TRANSPORTER C10; ABC TRANSPORTER C11; BISANTRENE; COLCHICINE; DOCETAXEL;

APICAL MEMBRANE; BIOINFORMATICS; DATA MINING; DRUG ABSORPTION; DRUG DISPOSITION; DRUG RESISTANCE; DRUG RESPONSE; DRUG TRANSPORT; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC DATABASE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE MAP; HUMAN; INDIVIDUALIZATION; MEDICAL LITERATURE; NATURAL SELECTION; PATIENT CARE; PHENOTYPE; POPULATION GENETICS; PROTEIN FAMILY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; DNA POLYMORPHISM; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; PHARMACOGENOMICS;

EID: 70249139920     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/187569209787582330     Document Type: Review

References (157)

1. Akey, J. M.; Zhang, G.; Zhang, K.; Jin, L. and Shriver, M. D. (2002) Interrogating a high-density SNP map for signatures of natural selection. Genome Res. 12, 1805-1814.
2. Belinsky, M. G.; Chen, Z. S.; Shchaveleva, I.; Zeng, H. and Kruh, G. D. (2002) Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res. 62, 6172-6177.
3. Bergen, A. A.; Plomp, A. S.; Hu, X.; de Jong, P. T. and Gorgels, T. G. (2007) ABCC6 and pseudoxanthoma elasticum. Pflugers Arch. 453, 685-691.
4. Bortfeld, M.; Rius, M.; Konig, J.; Herold-Mende, C.; Nies, A. T. and Keppler, D. (2006) Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system. Neuroscience 137, 1247-1257.
5. Bowen, A. R.; Gotting, C.; LeBoit, P. E. and McCalmont, T. H. (2007) Pseudoxanthoma elasticum-like fibers in the inflamed skin of patients without pseudoxanthoma elasticum. J. Cutan. Pathol. 34, 777-781.
6. Brookes, A. J. (1999) The essence of SNPs. Gene 234, 177-186.
7. Carlson, C. S.; Eberle, M. A.; Rieder, M. J.; Yi, Q.; Kruglyak, L. and Nickerson, D. A. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 74, 106-120.
8. Carlson, C. S.; Thomas, D. J.; Eberle, M. A.; Swanson, J. E.; Livingston, R. J.; Rieder, M. J. and Nickerson, D. A. (2005) Genomic regions exhibiting positive selection identified from dense genotype data. Genome Res. 15, 1553-1565.
9. Cartegni, L.; Wang, J.; Zhu, Z.; Zhang, M. Q. and Krainer, A. R. (2003) ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31, 3568-3571.
10. Cascorbi, I. (2006) Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol. Ther. 112, 457-473.
11. Chanock, S. J.; Manolio, T.; Boehnke, M.; Boerwinkle, E.; Hunter, D. J.; Thomas, G.; Hirschhorn, J. N.; Abecasis, G.; Altshuler, D.; Bailey-Wilson, J. E.; Brooks, L. D.; Cardon, L. R.; Daly, M.; Donnelly, P.; Fraumeni, J. F., Jr.; Freimer, N. B.; Gerhard, D. S.; Gunter, C.; Guttmacher, A. E.; Guyer, M. S.; Harris, E. L.; Hoh, J.; Hoover, R.; Kong, C. A.; Merikangas, K. R.; Morton, C. C.; Palmer, L. J.; Phimister, E. G.; Rice, J. P.; Roberts, J.; Rotimi, C.; Tucker, M. A.; Vogan, K. J.; Wacholder, S.; Wijsman, E. M.; Winn, D. M. and Collins, F. S. (2007) Replicating genotype-phenotype associations. Nature 447, 655-660.
12. Chen, C. J.; Chin, J. E.; Ueda, K.; Clark, D. P.; Pastan, I.; Gottesman, M. M. and Roninson, I. B. (1986) Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47, 381-389.
13. Childs, S.; Yeh, R. L.; Hui, D. and Ling, V. (1998) Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein. Cancer Res. 58, 4160-4167.
14. Choi, J. H.; Ahn, B. M.; Yi, J.; Lee, J. H.; Nam, S. W.; Chon, C. Y.; Han, K. H.; Ahn, S. H.; Jang, I. J.; Cho, J. Y.; Suh, Y.; Cho, M. O.; Lee, J. E.; Kim, K. H. and Lee, M. G. (2007) MRP2 haplotypes confer differential susceptibility to toxic liver injury. Pharmacogenet. Genomics 17, 403-415.
15. Choudhuri, S. and Klaassen, C. D. (2006) Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int. J. Toxicol. 25, 231-259.
16. Cole, S. P.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M. and Deeley, R. G. (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258, 1650-1654.
17. Conrad, S.; Kauffmann, H. M.; Ito, K.; Deeley, R. G.; Cole, S. P. and Schrenk, D. (2001) Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution. J. Hum. Genet. 46, 656-663.
18. Conrad, S.; Kauffmann, H. M.; Ito, K.; Leslie, E. M.; Deeley, R. G.; Schrenk, D. and Cole, S. P. (2002) A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance. Pharmacogenetics 12, 321-330.
19. Cousin, E.; Genin, E.; Mace, S.; Ricard, S.; Chansac, C.; del Zompo, M. and Deleuze, J. F. (2003) Association studies in candidate genes: strategies to select SNPs to be tested. Hum. Hered. 56, 151-159.
20. Cousin, E.; Deleuze, J. F. and Genin, E. (2006) Selection of SNP subsets for association studies in candidate genes: comparison of the power of different strategies to detect single disease susceptibility locus effects. BMC Genet. 7, 20.
21. Dean, M.; Rzhetsky, A. and Allikmets, R. (2001) The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 11, 1156-1166.
22. Deloukas, P. and Bentley, D. (2004) The HapMap project and its application to genetic studies of drug response. Pharmacogenomics J. 4, 88-90.
23. Ding, K. and Kullo, I. J. (2007) Methods for the selection of tagging SNPs: a comparison of tagging efficiency and performance. Eur. J. Hum. Genet. 15, 228-236.
24. Doerfel, C.; Rump, A.; Sauerbrey, A.; Gruhn, B.; Zintl, F. and Steinbach, D. (2006) In acute leukemia, the polymorphism -211C>T in the promoter region of the multidrug resistance-associated protein 3 (MRP3) does not determine the expression level of the gene. Pharmacogenet. Genomics 16, 149-150.
25. Drescher, S.; Schaeffeler, E.; Hitzl, M.; Hofmann, U.; Schwab, M.; Brinkmann, U.; Eichelbaum, M. and Fromm, M. F. (2002) MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br. J. Clin. Pharmacol. 53, 526-534.
26. Drozdzik, M.; Bialecka, M.; Mysliwiec, K.; Honczarenko, K.; Stankiewicz, J. and Sych, Z. (2003) Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. Pharmacogenetics 13, 259-263.
27. Eichelbaum, M.; Ingelman-Sundberg, M. and Evans, W. E. (2006) Pharmacogenomics and individualized drug therapy. Annu. Rev. Med. 57, 119-137.
28. Eloranta, M. L.; Hakli, T.; Hiltunen, M.; Helisalmi, S.; Punnonen, K. and Heinonen, S. (2003) Association of single nucleotide polymorphisms of the bile salt export pump gene with intrahepatic cholestasis of pregnancy. Scand. J. Gastroenterol. 38, 648-652.
29. Evans, W. E. and Relling, M. V. (1999) Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286, 487-491.
30. Evans, W. E. and McLeod, H. L. (2003) Pharmacogenomics-drug disposition, drug targets, and side effects. N. Engl. J. Med. 348, 538-549.
31. Fairbrother, W. G.; Yeh, R. F.; Sharp, P. A. and Burge, C. B. (2002) Predictive identification of exonic splicing enhancers in human genes. Science 297, 1007-1013.
32. Fairbrother, W. G.; Holste, D.; Burge, C. B. and Sharp, P. A. (2004) Single nucleotide polymorphism-based validation of exonic splicing enhancers. PLoS Biol. 2, E268.
33. Fellay, J.; Marzolini, C.; Meaden, E. R.; Back, D. J.; Buclin, T.; Chave, J. P.; Decosterd, L. A.; Furrer, H.; Opravil, M.; Pantaleo, G.; Retelska, D.; Ruiz, L.; Schinkel, A. H.; Vernazza, P.; Eap, C. B. and Telenti, A. (2002) Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 359, 30-36.
34. Fukushima-Uesaka, H.; Saito, Y.; Maekawa, K.; Hasegawa, R.; Suzuki, K.; Yanagawa, T.; Kajio, H.; Kuzuya, N.; Noda, M.; Yasuda, K.; Tohkin, M. and Sawada, J. (2007) Genetic variations of the ABC transporter gene ABCC3 in a Japanese population. Drug Metab. Pharmacokinet. 22, 129-135.
35. Furuno, T.; Landi, M. T.; Ceroni, M.; Caporaso, N.; Bernucci, I.; Nappi, G.; Martignoni, E.; Schaeffeler, E.; Eichelbaum, M.; Schwab, M. and Zanger, U. M. (2002) Expression polymorphism of the blood-brain barrier component P- glycoprotein (MDR1) in relation to Parkinson's disease. Pharmacogenetics 12, 529-534.
36. Gerken, T. A.; Tep, C. and Rarick, J. (2004) Role of peptide sequence and neighboring residue glycosylation on the substrate specificity of the uridine 5′-diphosphate-alpha-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyl transferases T1 and T2: kinetic modeling of the porcine and canine submaxillary gland mucin tandem repeats. Biochemistry 43, 9888-9900.
37. Glavinas, H.; Krajcsi, P.; Cserepes, J. and Sarkadi, B. (2004) The role of ABC transporters in drug resistance, metabolism and toxicity. Curr. Drug Deliv. 1, 27-42.
38. Goldstein, D. B.; Ahmadi, K. R.; Weale, M. E. and Wood, N. W. (2003) Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. Trends Genet. 19, 615-622.
39. Goren, A.; Ram, O.; Amit, M.; Keren, H.; Lev-Maor, G.; Vig, I.; Pupko, T. and Ast, G. (2006) Comparative analysis identifies exonic splicing regulatory sequences-The complex definition of enhancers and silencers. Mol. Cell 22, 769-781.
40. Gradhand, U.; Tegude, H.; Burk, O.; Eichelbaum, M.; Fromm, M. F. and Konig, J. (2007) Functional analysis of the polymorphism -211C>T in the regulatory region of the human ABCC3 gene. Life Sci. 80, 1490-1494.
41. Guo, Y.; Kotova, E.; Chen, Z. S.; Lee, K.; Hopper-Borge, E.; Belinsky, M. G. and Kruh, G. D. (2003) MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′,3′-dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl)adenine. J. Biol. Chem. 278, 29509-29514.
42. Gwee, P. C.; Tang, K.; Sew, P. H.; Lee, E. J.; Chong, S. S. and Lee, C. G. (2005) Strong linkage disequilibrium at the nucleotide analogue transporter ABCC5 gene locus. Pharmacogenet. Genomics 15, 91-104.
43. Haenisch, S.; Zimmermann, U.; Dazert, E.; Wruck, C. J.; Dazert, P.; Siegmund, S.; Kroemer, H. K.; Warzok, R. W. and Cascorbi, I. (2007) Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex. Pharmacogenomics J. 7, 56-65.
44. Halldorsson, B. V.; Bafna, V.; Lippert, R.; Schwartz, R.; De La Vega, F. M.; Clark, A. G. and Istrail, S. (2004) Optimal haplotype block-free selection of tagging SNPs for genome-wide association studies. Genome Res. 14, 1633-1640.
45. Heinemeyer, T.; Wingender, E.; Reuter, I.; Hermjakob, H.; Kel, A. E.; Kel, O. V.; Ignatieva, E. V.; Ananko, E. A.; Podkolodnaya, O. A.; Kolpakov, F. A.; Podkolodny, N. L. and Kolchanov, N. A. (1998) Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26, 362-367.
46. Hipfner, D. R.; Deeley, R. G. and Cole, S. P. (1999) Structural, mechanistic and clinical aspects of MRP1. Biochim. Biophys. Acta 1461, 359-376.
47. Hirouchi, M.; Suzuki, H.; Itoda, M.; Ozawa, S.; Sawada, J.; Ieiri, I.; Ohtsubo, K. and Sugiyama, Y. (2004) Characterization of the cellular localization, expression level, and function of SNP variants of MRP2/ ABCC2. Pharm. Res. 21, 742-748.
48. Hitzl, M.; Drescher, S.; van der Kuip, H.; Schaffeler, E.; Fischer, J.; Schwab, M.; Eichelbaum, M. and Fromm, M. F. (2001) The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics 11, 293-298.
49. Hoffmeyer, S.; Burk, O.; von Richter, O.; Arnold, H. P.; Brockmoller, J.; Johne, A.; Cascorbi, I.; Gerloff, T.; Roots, I.; Eichelbaum, M. and Brinkmann, U. (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P- glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. USA 97, 3473-3478.
50. Hopper-Borge, E.; Chen, Z. S.; Shchaveleva, I.; Belinsky, M. G. and Kruh, G. D. (2004) Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel. Cancer Res. 64, 4927-4930.
51. Huang, H. D.; Lee, T. Y.; Tzeng, S. W. and Horng, J. T. (2005) KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites. Nucleic Acids Res. 33, W226-229.
52. Illmer, T.; Schuler, U. S.; Thiede, C.; Schwarz, U. I.; Kim, R. B.; Gotthard, S.; Freund, D.; Schakel, U.; Ehninger, G. and Schaich, M. (2002) MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res. 62, 4955-4962.
53. Imai, Y.; Nakane, M.; Kage, K.; Tsukahara, S.; Ishikawa, E.; Tsuruo, T.; Miki, Y. and Sugimoto, Y. (2002) C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol. Cancer Ther. 1, 611-616.
54. Ishikawa, T.; Tsuji, A.; Inui, K.; Sai, Y.; Anzai, N.; Wada, M.; Endou, H. and Sumino, Y. (2004) The genetic polymorphism of drug transporters: functional analysis approaches. Pharmacogenomics 5, 67-99.
55. Jensen, L. E.; Wall, A. M.; Cook, M.; Hoess, K.; Thorn, C. F.; Whitehead, A. S. and Mitchell, L. E. (2004) A common ABCC2 promoter polymorphism is not a determinant of the risk of spina bifida. Birth Defects Res. A Clin. Mol. Teratol. 70, 396-399.
56. Jeong, H.; Herskowitz, I.; Kroetz, D. L. and Rine, J. (2007) Function-altering SNPs in the human multidrug transporter gene ABCB1 identified using a Saccharomyces-based assay. PLoS Genet. 3, e39.
57. Johnson, G. C.; Esposito, L.; Barratt, B. J.; Smith, A. N.; Heward, J.; Di Genova, G.; Ueda, H.; Cordell, H. J.; Eaves, I. A.; Dudbridge, F.; Twells, R. C.; Payne, F.; Hughes, W.; Nutland, S.; Stevens, H.; Carr, P.; Tuomilehto-Wolf, E.; Tuomilehto, J.; Gough, S. C.; Clayton, D. G. and Todd, J. A. (2001) Haplotype tagging for the identification of common disease genes. Nat. Genet. 29, 233-237.
58. Juliano, R. L. and Ling, V. (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455, 152-162.
59. Kage, K.; Tsukahara, S.; Sugiyama, T.; Asada, S.; Ishikawa, E.; Tsuruo, T. and Sugimoto, Y. (2002) Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int. J. Cancer 97, 626-630.
60. Kao, S. L.; Chong, S. S. and Lee, C. G. (2000) The role of single nucleotide polymorphisms (SNPs) in understanding complex disorders and pharmacogenomics. Ann. Acad. Med. Singapore 29, 376-382.
61. Karchin, R.; Diekhans, M.; Kelly, L.; Thomas, D. J.; Pieper, U.; Eswar, N.; Haussler, D. and Sali, A. (2005) LS-SNP: large-scale annotation of coding non-synonymous SNPs based on multiple information sources. Bioinformatics 21, 2814-2820.
62. Keitel, V.; Kartenbeck, J.; Nies, A. T.; Spring, H.; Brom, M. and Keppler, D. (2000) Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology 32, 1317-1328.
63. Keitel, V.; Vogt, C.; Haussinger, D. and Kubitz, R. (2006) Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. Gastroenterology 131, 624-629.
64. Kelley, J. L.; Madeoy, J.; Calhoun, J. C.; Swanson, W. and Akey, J. M. (2006) Genomic signatures of positive selection in humans and the limits of outlier approaches. Genome Res. 16, 980-989.
65. Kent, W. J.; Sugnet, C. W.; Furey, T. S.; Roskin, K. M.; Pringle, T. H.; Zahler, A. M. and Haussler, D. (2002) The human genome browser at UCSC. Genome Res. 12, 996-1006.
66. Kimchi-Sarfaty, C.; Oh, J. M.; Kim, I. W.; Sauna, Z. E.; Calcagno, A. M.; Ambudkar, S. V. and Gottesman, M. M. (2007) A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315, 525-528.
67. Knight, J. C.; Keating, B. J.; Rockett, K. A. and Kwiatkowski, D. P. (2003) In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat. Genet. 33, 469-475.
68. Kobayashi, D.; Ieiri, I.; Hirota, T.; Takane, H.; Maegawa, S.; Kigawa, J.; Suzuki, H.; Nanba, E.; Oshimura, M.; Terakawa, N.; Otsubo, K.; Mine, K. and Sugiyama, Y. (2005) Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab. Dispos. 33, 94-101.
69. Kondo, C.; Suzuki, H.; Itoda, M.; Ozawa, S.; Sawada, J.; Kobayashi, D.; Ieiri, I.; Mine, K.; Ohtsubo, K. and Sugiyama, Y. (2004) Functional analysis of SNPs variants of BCRP/ABCG2. Pharm. Res. 21, 1895-1903.
70. Kruh, G. D.; Guo, Y.; Hopper-Borge, E.; Belinsky, M. G. and Chen, Z. S. (2007) ABCC10, ABCC11, and ABCC12. Pflugers Arch. 453, 675-684.
71. Laing, N. M.; Belinsky, M. G.; Kruh, G. D.; Bell, D. W.; Boyd, J. T.; Barone, L.; Testa, J. R. and Tew, K. D. (1998) Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells. Cancer Res. 58, 1332-1337.
72. Lang, C.; Meier, Y.; Stieger, B.; Beuers, U.; Lang, T.; Kerb, R.; Kullak- Ublick, G. A.; Meier, P. J. and Pauli-Magnus, C. (2007) Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet. Genomics 17, 47-60.
73. Lee, C. G.; Gottesman, M. M.; Cardarelli, C. O.; Ramachandra, M.; Jeang, K. T.; Ambudkar, S. V.; Pastan, I. and Dey, S. (1998) HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry 37, 3594-3601.
74. Lee, C. G.; Tang, K.; Cheung, Y. B.; Wong, L. P.; Tan, C.; Shen, H.; Zhao, Y.; Pavanni, R.; Lee, E. J.; Wong, M. C.; Chong, S. S. and Tan, E. K. (2004) MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic Chinese. J. Med. Genet. 41, e60.
75. Lee, P. H. and Shatkay, H. (2008) F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res. 36, D820-824.
76. Leslie, E. M.; Deeley, R. G. and Cole, S. P. (2001) Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 167, 3-23.
77. Letourneau, I. J.; Deeley, R. G. and Cole, S. P. (2005) Functional characterization of non-synonymous single nucleotide polymorphisms in the gene encoding human multidrug resistance protein 1 (MRP1/ABCC1). Pharmacogenet. Genomics 15, 647-657.
78. Lin, J. H. and Yamazaki, M. (2003) Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin. Pharmacokinet. 42, 59-98.
79. Little, S. (2006) Translating single nucleotide polymorphism tests from clinical research to clinical practice. Person. Med. 3, 95-99.
80. Lockhart, A. C.; Tirona, R. G. and Kim, R. B. (2003) Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy. Mol. Cancer Ther. 2, 685-698.
81. Luciani, M. F.; Denizot, F.; Savary, S.; Mattei, M. G. and Chimini, G. (1994) Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics 21, 150-159.
82. Mace, S.; Cousin, E.; Ricard, S.; Genin, E.; Spanakis, E.; Lafargue- Soubigou, C.; Genin, B.; Fournel, R.; Roche, S.; Haussy, G.; Massey, F.; Soubigou, S.; Brefort, G.; Benoit, P.; Brice, A.; Campion, D.; Hollis, M.; Pradier, L.; Benavides, J. and Deleuze, J. F. (2005) ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease. Neurobiol. Dis. 18, 119-125.
83. Machida, I.; Wakusawa, S.; Sanae, F.; Hayashi, H.; Kusakabe, A.; Ninomiya, H.; Yano, M. and Yoshioka, K. (2005) Mutational analysis of the MRP2 gene and long-term follow-up of Dubin-Johnson syndrome in Japan. J. Gastroenterol. 40, 366-370.
84. Mack, J. T.; Townsend, D. M.; Beljanski, V. and Tew, K. D. (2007) The ABCA2 transporter: intracellular roles in trafficking and metabolism of LDL-derived cholesterol and sterol-related compounds. Curr. Drug Metab. 8, 47-57.
85. Materna, V. and Lage, H. (2003) Homozygous mutation Arg768Trp in the ABC-transporter encoding gene MRP2/cMOAT/ABCC2 causes Dubin-Johnson syndrome in a Caucasian patient. J. Hum. Genet. 48, 484-486.
86. Mathijssen, R. H.; Marsh, S.; Karlsson, M. O.; Xie, R.; Baker, S. D.; Verweij, J.; Sparreboom, A. and McLeod, H. L. (2003) Irinotecan pathway genotype analysis to predict pharmacokinetics. Clin. Cancer Res. 9, 3246-3253.
87. Meyer zu Schwabedissen, H. E.; Jedlitschky, G.; Gratz, M.; Haenisch, S.; Linnemann, K.; Fusch, C.; Cascorbi, I. and Kroemer, H. K. (2005) Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation. Drug Metab. Dispos. 33, 896-904.
88. Mizuarai, S.; Aozasa, N. and Kotani, H. (2004) Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2. Int. J. Cancer 109, 238-246.
89. Monigatti, F.; Gasteiger, E.; Bairoch, A. and Jung, E. (2002) The Sulfinator: predicting tyrosine sulfation sites in protein sequences. Bioinformatics 18, 769-770.
90. Mor-Cohen, R.; Zivelin, A.; Rosenberg, N.; Shani, M.; Muallem, S. and Seligsohn, U. (2001) Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome. J. Biol. Chem. 276, 36923-36930.
91. Morisaki, K.; Robey, R. W.; Ozvegy-Laczka, C.; Honjo, Y.; Polgar, O.; Steadman, K.; Sarkadi, B. and Bates, S. E. (2005) Single nucleotide polymorphisms modify the transporter activity of ABCG2. Cancer Chemother. Pharmacol. 56, 161-172.
92. Moriya, Y.; Nakamura, T.; Horinouchi, M.; Sakaeda, T.; Tamura, T.; Aoyama, N.; Shirakawa, T.; Gotoh, A.; Fujimoto, S.; Matsuo, M.; Kasuga, M. and Okumura, K. (2002) Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects. Biol. Pharm. Bull. 25, 1356-1359.
93. Mottagui-Tabar, S.; Faghihi, M. A.; Mizuno, Y.; Engstrom, P. G.; Lenhard, B.; Wasserman, W. W. and Wahlestedt, C. (2005) Identification of functional SNPs in the 5-prime flanking sequences of human genes. BMC Genomics 6, 18.
94. Naesens, M.; Kuypers, D. R.; Verbeke, K. and Vanrenterghem, Y. (2006) Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients. Transplantation 82, 1074-1084.
95. Ng, P. C. and Henikoff, S. (2003) SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 31, 3812-3814.
96. Nielsen, D. M.; Ehm, M. G. and Weir, B. S. (1998) Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am. J. Hum. Genet. 63, 1531-1540.
97. Nielsen, R.; Williamson, S.; Kim, Y.; Hubisz, M. J.; Clark, A. G. and Bustamante, C. (2005) Genomic scans for selective sweeps using SNP data. Genome Res. 15, 1566-1575.
98. Niemi, M.; Arnold, K. A.; Backman, J. T.; Pasanen, M. K.; Godtel- Armbrust, U.; Wojnowski, L.; Zanger, U. M.; Neuvonen, P. J.; Eichelbaum, M.; Kivisto, K. T. and Lang, T. (2006) Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance- associated protein 2 expression and pravastatin pharmacokinetics. Pharmacogenet. Genomics 16, 801-808.
99. Oselin, K.; Mrozikiewicz, P. M.; Gaikovitch, E.; Pahkla, R. and Roots, I. (2003) Frequency of MRP1 genetic polymorphisms and their functional significance in Caucasians: detection of a novel mutation G816A in the human MRP1 gene. Eur. J. Clin. Pharmacol. 59, 347-350.
100. Pardi, F.; Lewis, C. M. and Whittaker, J. C. (2005) SNP selection for association studies: maximizing power across SNP choice and study size. Ann. Hum. Genet. 69, 733-746.
101. Ramensky, V.; Bork, P. and Sunyaev, S. (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30, 3894-3900.
102. Rau, T.; Erney, B.; Gores, R.; Eschenhagen, T.; Beck, J. and Langer, T. (2006) High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations. Clin. Pharmacol. Ther. 80, 468-476.
103. Rebbeck, T. R.; Spitz, M. and Wu, X. (2004) Assessing the function of genetic variants in candidate gene association studies. Nat. Rev. Genet. 5, 589-597.
104. Reumers, J.; Schymkowitz, J.; Ferkinghoff-Borg, J.; Stricher, F.; Serrano, L. and Rousseau, F. (2005) SNPeffect: a database mapping molecular phenotypic effects of human non-synonymous coding SNPs. Nucleic Acids Res. 33, D527-532.
105. Riordan, J. R.; Deuchars, K.; Kartner, N.; Alon, N.; Trent, J. and Ling, V. (1985) Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 316, 817-819.
106. Rochat, R. H.; de las Fuentes, L.; Stormo, G.; Davila-Roman, V. G. and Gu, C. C. (2007) A novel method combining linkage disequilibrium information and imputed functional knowledge for tagSNP selection. Hum. Hered. 64, 243-249.
107. Rost, D.; Konig, J.; Weiss, G.; Klar, E.; Stremmel, W. and Keppler, D. (2001) Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia. Gastroenterology 121, 1203-1208.
108. Sabeti, P. C.; Reich, D. E.; Higgins, J. M.; Levine, H. Z.; Richter, D. J.; Schaffner, S. F.; Gabriel, S. B.; Platko, J. V.; Patterson, N. J.; McDonald, G. J.; Ackerman, H. C.; Campbell, S. J.; Altshuler, D.; Cooper, R.; Kwiatkowski, D.; Ward, R. and Lander, E. S. (2002) Detecting recent positive selection in the human genome from haplotype structure. Nature 419, 832-837.
109. Sabeti, P. C.; Varilly, P.; Fry, B.; Lohmueller, J.; Hostetter, E.; Cotsapas, C.; Xie, X.; Byrne, E. H.; McCarroll, S. A.; Gaudet, R.; Schaffner, S. F.; Lander, E. S.; Frazer, K. A.; Ballinger, D. G.; Cox, D. R.; Hinds, D. A.; Stuve, L. L.; Gibbs, R. A.; Belmont, J. W.; Boudreau, A.; Hardenbol, P.; Leal, S. M.; Pasternak, S.; Wheeler, D. A.; Willis, T. D.; Yu, F.; Yang, H.; Zeng, C.; Gao, Y.; Hu, H.; Hu, W.; Li, C.; Lin, W.; Liu, S.; Pan, H.; Tang, X.; Wang, J.; Wang, W.; Yu, J.; Zhang, B.; Zhang, Q.; Zhao, H.; Zhou, J.; Gabriel, S. B.; Barry, R.; Blumenstiel, B.; Camargo, A.; Defelice, M.; Faggart, M.; Goyette, M.; Gupta, S.; Moore, J.; Nguyen, H.; Onofrio, R. C.; Parkin, M.; Roy, J.; Stahl, E.; Winchester, E.; Ziaugra, L.; Altshuler, D.; Shen, Y.; Yao, Z.; Huang, W.; Chu, X.; He, Y.; Jin, L.; Liu, Y.; Sun, W.; Wang, H.; Wang, Y.; Xiong, X.; Xu, L.; Waye, M. M.; Tsui, S. K.; Xue, H.; Wong, J. T.; Galver, L. M.; Fan, J. B.; Gunderson, K.; Murray, S. S.; Oliphant, A. R.; Chee, M. S.; Montpetit, A.; Chagnon, F.; Ferretti, V.; Leboeuf, M.; Olivier, J. F.; Phillips, M. S.; Roumy, S.; Sallee, C.; Verner, A.; Hudson, T. J.; Kwok, P. Y.; Cai, D.; Koboldt, D. C.; Miller, R. D.; Pawlikowska, L.; Taillon-Miller, P.; Xiao, M.; et al. (2007) Genome-wide detection and characterization of positive selection in human populations. Nature 449, 913-918.
110. Sakai, H.; Tanaka, Y.; Tanaka, M.; Ban, N.; Yamada, K.; Matsumura, Y.; Watanabe, D.; Sasaki, M.; Kita, T. and Inagaki, N. (2007) ABCA2 deficiency results in abnormal sphingolipid metabolism in mouse brain. J. Biol. Chem. 282, 19692-19699.
111. Sandelin, A.; Wasserman, W. W. and Lenhard, B. (2004) ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res. 32, W249-252.
112. Schinkel, A. H.; Smit, J. J.; van Tellingen, O.; Beijnen, J. H.; Wagenaar, E.; van Deemter, L.; Mol, C. A.; van der Valk, M. A.; Robanus-Maandag, E. C.; te Riele, H. P.; Berns, A. J. and Borst, P. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491-502.
113. Schmith, V. D.; Campbell, D. A.; Sehgal, S.; Anderson, W. H.; Burns, D. K.; Middleton, L. T. and Roses, A. D. (2003) Pharmacogenetics and disease genetics of complex diseases. Cell Mol Life Sci. 60, 1636-1646.
114. Schulz, V.; Hendig, D.; Henjakovic, M.; Szliska, C.; Kleesiek, K. and Gotting, C. (2006) Mutational analysis of the ABCC6 gene and the proximal ABCC6 gene promoter in German patients with pseudoxanthoma elasticum (PXE). Hum. Mutat. 27, 831.
115. Schwab, M.; Schaeffeler, E.; Marx, C.; Fromm, M. F.; Kaskas, B.; Metzler, J.; Stange, E.; Herfarth, H.; Schoelmerich, J.; Gregor, M.; Walker, S.; Cascorbi, I.; Roots, I.; Brinkmann, U.; Zanger, U. M. and Eichelbaum, M. (2003) Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 124, 26-33.
116. Scott, L. J.; Mohlke, K. L.; Bonnycastle, L. L.; Willer, C. J.; Li, Y.; Duren, W. L.; Erdos, M. R.; Stringham, H. M.; Chines, P. S.; Jackson, A. U.; Prokunina-Olsson, L.; Ding, C. J.; Swift, A. J.; Narisu, N.; Hu, T.; Pruim, R.; Xiao, R.; Li, X. Y.; Conneely, K. N.; Riebow, N. L.; Sprau, A. G.; Tong, M.; White, P. P.; Hetrick, K. N.; Barnhart, M. W.; Bark, C. W.; Goldstein, J. L.; Watkins, L.; Xiang, F.; Saramies, J.; Buchanan, T. A.; Watanabe, R. M.; Valle, T. T.; Kinnunen, L.; Abecasis, G. R.; Pugh, E. W.; Doheny, K. F.; Bergman, R. N.; Tuomilehto, J.; Collins, F. S. and Boehnke, M. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341-1345.
117. Shastry, B. S. (2006) Pharmacogenetics and the concept of individualized medicine. Pharmacogenomics J. 6, 16-21.
118. Siegsmund, M.; Brinkmann, U.; Schaffeler, E.; Weirich, G.; Schwab, M.; Eichelbaum, M.; Fritz, P.; Burk, O.; Decker, J.; Alken, P.; Rothenpieler, U.; Kerb, R.; Hoffmeyer, S. and Brauch, H. (2002) Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J. Am. Soc. Nephrol. 13, 1847-1854.
119. Smith, P. J.; Zhang, C.; Wang, J.; Chew, S. L.; Zhang, M. Q. and Krainer, A. R. (2006) An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum. Mol. Genet. 15, 2490-2508.
120. Sparreboom, A.; Gelderblom, H.; Marsh, S.; Ahluwalia, R.; Obach, R.; Principe, P.; Twelves, C.; Verweij, J. and McLeod, H. L. (2004) Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype. Clin. Pharmacol. Ther. 76, 38-44.
121. Sparreboom, A.; Loos, W. J.; Burger, H.; Sissung, T. M.; Verweij, J.; Figg, W. D.; Nooter, K. and Gelderblom, H. (2005) Effect of ABCG2 genotype on the oral bioavailability of topotecan. Cancer Biol. Ther. 4, 650-658.
122. Stram, D. O.; Haiman, C. A.; Hirschhorn, J. N.; Altshuler, D.; Kolonel, L. N.; Henderson, B. E. and Pike, M. C. (2003) Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multi-ethnic Cohort Study. Hum. Hered. 55, 27-36.
123. Strautnieks, S. S.; Bull, L. N.; Knisely, A. S.; Kocoshis, S. A.; Dahl, N.; Arnell, H.; Sokal, E.; Dahan, K.; Childs, S.; Ling, V.; Tanner, M. S.; Kagalwalla, A. F.; Nemeth, A.; Pawlowska, J.; Baker, A.; Mieli-Vergani, G.; Freimer, N. B.; Gardiner, R. M. and Thompson, R. J. (1998) A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet. 20, 233-238.
124. Szakacs, G.; Paterson, J. K.; Ludwig, J. A.; Booth-Genthe, C. and Gottesman, M. M. (2006) Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 5, 219-234.
125. Tamura, A.; Wakabayashi, K.; Onishi, Y.; Nakagawa, H.; Tsuji, M.; Matsuda, Y. and Ishikawa, T. (2006) Genetic polymorphisms of human ABC transporter ABCG2: development of the standard method for functional validation of SNPs by using the Flp recombinase system. J. Exp. Ther. Oncol. 6, 1-11.
126. Tamura, A.; Wakabayashi, K.; Onishi, Y.; Takeda, M.; Ikegami, Y.; Sawada, S.; Tsuji, M.; Matsuda, Y. and Ishikawa, T. (2007) Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2. Cancer Sci. 98, 231-239.
127. Tan, E. K.; Drozdzik, M.; Bialecka, M.; Honczarenko, K.; Klodowska-Duda, G.; Teo, Y. Y.; Tang, K.; Wong, L. P.; Chong, S. S.; Tan, C.; Yew, K.; Zhao, Y. and Lee, C. G. (2004) Analysis of MDR1 haplotypes in Parkinson's disease in a white population. Neurosci. Lett. 372, 240-244.
128. Tan, E. K.; Chan, D. K.; Ng, P. W.; Woo, J.; Teo, Y. Y.; Tang, K.; Wong, L. P.; Chong, S. S.; Tan, C.; Shen, H.; Zhao, Y. and Lee, C. G. (2005) Effect of MDR1 haplotype on risk of Parkinson disease. Arch. Neurol. 62, 460-464.
129. Tang, K.; Wong, L. P.; Lee, E. J.; Chong, S. S. and Lee, C. G. (2004) Genomic evidence for recent positive selection at the human MDR1 gene locus. Hum. Mol. Genet. 13, 783-797.
130. Tang, K.; Thornton, K. R. and Stoneking, M. (2007) A New Approach for Using Genome Scans to Detect Recent Positive Selection in the Human Genome. PLoS Biol. 5, e171.
131. The International Hapmap Consortium. (2003) The International HapMap Project. Nature 426, 789-796.
132. Thomas, P. D. and Kejariwal, A. (2004) Coding single-nucleotide polymorphisms associated with complex vs. Mendelian disease: evolutionary evidence for differences in molecular effects. Proc. Natl. Acad. Sci. USA 101, 15398-15403.
133. Tomlinson, I.; Webb, E.; Carvajal-Carmona, L.; Broderick, P.; Kemp, Z.; Spain, S.; Penegar, S.; Chandler, I.; Gorman, M.; Wood, W.; Barclay, E.; Lubbe, S.; Martin, L.; Sellick, G.; Jaeger, E.; Hubner, R.; Wild, R.; Rowan, A.; Fielding, S.; Howarth, K.; Silver, A.; Atkin, W.; Muir, K.; Logan, R.; Kerr, D.; Johnstone, E.; Sieber, O.; Gray, R.; Thomas, H.; Peto, J.; Cazier, J. B. and Houlston, R. (2007) A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet. 39, 984-988.
134. Trip, M. D.; Smulders, Y. M.; Wegman, J. J.; Hu, X.; Boer, J. M.; ten Brink, J. B.; Zwinderman, A. H.; Kastelein, J. J.; Feskens, E. J. and Bergen, A. A. (2002) Frequent mutation in the ABCC6 gene (R1141X) is associated with a strong increase in the prevalence of coronary artery disease. Circulation 106, 773-775.
135. Twyman, R. M. and Primrose, S. B. (2003) Techniques patents for SNP genotyping. Pharmacogenomics 4, 67-79.
136. van den Heuvel-Eibrink, M. M.; Wiemer, E. A.; de Boevere, M. J.; van der Holt, B.; Vossebeld, P. J.; Pieters, R. and Sonneveld, P. (2001) MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia. Blood 97, 3605-3611.
137. van Es, M. A.; Van Vught, P. W.; Blauw, H. M.; Franke, L.; Saris, C. G.; Andersen, P. M.; Van Den Bosch, L.; de Jong, S. W.; van 't Slot, R.; Birve, A.; Lemmens, R.; de Jong, V.; Baas, F.; Schelhaas, H. J.; Sleegers, K.; Van Broeckhoven, C.; Wokke, J. H.; Wijmenga, C.; Robberecht, W.; Veldink, J. H.; Ophoff, R. A. and van den Berg, L. H. (2007) ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol. 6, 869-877.
138. Voight, B. F.; Kudaravalli, S.; Wen, X. and Pritchard, J. K. (2006) A map of recent positive selection in the human genome. PLoS Biol. 4, e72.
139. Vulevic, B.; Chen, Z.; Boyd, J. T.; Davis, W., Jr.; Walsh, E. S.; Belinsky, M. G. and Tew, K. D. (2001) Cloning and characterization of human adenosine 5′-triphosphate-binding cassette, sub-family A, transporter 2 (ABCA2). Cancer Res. 61, 3339-3347.
140. Wang, E. T.; Kodama, G.; Baldi, P. and Moyzis, R. K. (2006) Global landscape of recent inferred Darwinian selection for Homo sapiens. Proc. Natl. Acad. Sci. USA 103, 135-140.
141. Wang, H.; Ding, K.; Zhang, Y.; Jin, L.; Kullo, I. J. and He, F. (2007) Comparative and evolutionary pharmacogenetics of ABCB1: complex signatures of positive selection on coding and regulatory regions. Pharmacogenet. Genomics 17, 667-678.
142. Wang, J.; Near, S.; Young, K.; Connelly, P. W. and Hegele, R. A. (2001) ABCC6 gene polymorphism associated with variation in plasma lipoproteins. J. Hum. Genet. 46, 699-705.
143. Wang, Z.; Rolish, M. E.; Yeo, G.; Tung, V.; Mawson, M. and Burge, C. B. (2004) Systematic identification and analysis of exonic splicing silencers. Cell 119, 831-845.
144. Wang, Z.; Wang, B.; Tang, K.; Lee, E. J.; Chong, S. S. and Lee, C. G. (2005) A functional polymorphism within the MRP1 gene locus identified through its genomic signature of positive selection. Hum. Mol. Genet. 14, 2075-2087.
145. Wang, Z.; Sew, P. H.; Ambrose, H.; Ryan, S.; Chong, S. S.; Lee, E. J. and Lee, C. G. (2006) Nucleotide sequence analyses of the MRP1 gene in four populations suggest negative selection on its coding region. BMC Genomics 7, 111.
146. Wang, Z.; Chong, S. S. and Lee, C. G. (2007a) Characterization of Single Nucleotide Polymorphisms in 13 Members of the ABC Drug Transporter Genes in Three Different Populations. Open Pharmacol. J. 1, 1-12.
147. Wang, Z.; Wang, J.; Tantoso, E.; Wang, B.; Tai, A. Y.; Ooi, L. L.; Chong, S. S. and Lee, C. G. (2007b) Signatures of recent positive selection at the ATP-binding cassette drug transporter superfamily gene loci. Hum. Mol. Genet. 16, 1367-1380.
148. Weale, M. E.; Depondt, C.; Macdonald, S. J.; Smith, A.; Lai, P. S.; Shorvon, S. D.; Wood, N. W. and Goldstein, D. B. (2003) Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: implications for linkage-disequilibrium gene mapping. Am. J. Hum. Genet. 73, 551-565.
149. Weinshilboum, R. (2003) Inheritance and drug response. N. Engl. J. Med. 348, 529-537.
150. Wollmer, M. A.; Kapaki, E.; Hersberger, M.; Muntwyler, J.; Brunner, F.; Tsolaki, M.; Akatsu, H.; Kosaka, K.; Michikawa, M.; Molyva, D.; Paraskevas, G. P.; Lutjohann, D.; von Eckardstein, A.; Hock, C.; Nitsch, R. M. and Papassotiropoulos, A. (2006) Ethnicity-dependent genetic association of ABCA2 with sporadic Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141, 534-536.
151. Wooden, S. L.; Kalb, S. R.; Cotter, R. J. and Soloski, M. J. (2005) Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis. J. Immunol. 175, 1383-1387.
152. Yoshiura, K.; Kinoshita, A.; Ishida, T.; Ninokata, A.; Ishikawa, T.; Kaname, T.; Bannai, M.; Tokunaga, K.; Sonoda, S.; Komaki, R.; Ihara, M.; Saenko, V. A.; Alipov, G. K.; Sekine, I.; Komatsu, K.; Takahashi, H.; Nakashima, M.; Sosonkina, N.; Mapendano, C. K.; Ghadami, M.; Nomura, M.; Liang, D. S.; Miwa, N.; Kim, D. K.; Garidkhuu, A.; Natsume, N.; Ohta, T.; Tomita, H.; Kaneko, A.; Kikuchi, M.; Russomando, G.; Hirayama, K.; Ishibashi, M.; Takahashi, A.; Saitou, N.; Murray, J. C.; Saito, S.; Nakamura, Y. and Niikawa, N. (2006) A SNP in the ABCC11 gene is the determinant of human earwax type. Nat. Genet. 38, 324-330.
153. Yue, P.; Melamud, E. and Moult, J. (2006) SNPs3D: candidate gene and SNP selection for association studies. BMC Bioinformatics 7, 166.
154. Zelcer, N.; Saeki, T.; Reid, G.; Beijnen, J. H. and Borst, P. (2001) Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J. Biol. Chem. 276, 46400-46407.
155. Zhang, C.; Bailey, D. K.; Awad, T.; Liu, G.; Xing, G.; Cao, M.; Valmeekam, V.; Retief, J.; Matsuzaki, H.; Taub, M.; Seielstad, M. and Kennedy, G. C. (2006) A whole genome long-range haplotype (WGLRH) test for detecting imprints of positive selection in human populations. Bioinformatics 22, 2122-2128.
156. Zhang, X. H. and Chasin, L. A. (2004) Computational definition of sequence motifs governing constitutive exon splicing. Genes Dev. 18, 1241-1250.
157. Zhang, X. H.; Kangsamaksin, T.; Chao, M. S.; Banerjee, J. K. and Chasin, L. A. (2005) Exon inclusion is dependent on predictable exonic splicing enhancers. Mol. Cell Biol. 25, 7323-7332.